Comparison of efficacy and safety of bevacizumab biosimilar and original bevacizumab in non-squamous non-small cell lung cancer: a systematic review and meta-analysis
Author(s) -
Xian Xiao,
Guixing Zhang,
Binxu Sun,
Chaoran Wang,
Xiaoqun Wang,
Fanming Kong,
Yingjie Jia
Publication year - 2022
Publication title -
translational cancer research
Language(s) - English
Resource type - Journals
eISSN - 2219-6803
pISSN - 2218-676X
DOI - 10.21037/tcr-22-71
Subject(s) - bevacizumab , medicine , biosimilar , oncology , lung cancer , carboplatin , meta analysis , randomized controlled trial , adverse effect , cochrane library , chemotherapy , cisplatin
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom